Bridge to HOPE Trial Demonstrates Promising Findings with Hypothermic Oxygenated Perfusion
Bridge to Life Ltd., a leading global supplier of organ preservation and perfusion technologies, announced results from interim analysis of its multicenter, randomized, controlled liver clinical trial presented at the 2023 American Transplant Congress (ATC).